Loading...
Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease
BACKGROUND: Individuals with chronic bronchitis or chronic obstructive pulmonary disease (COPD) may suffer recurrent exacerbations with an increase in volume or purulence of sputum, or both. Personal and healthcare costs associated with exacerbations indicate that therapies that reduce the occurrenc...
Na minha lista:
| Udgivet i: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley & Sons, Ltd
2019
|
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6527426/ https://ncbi.nlm.nih.gov/pubmed/31107966 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD001287.pub6 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|